Clinical Utility of 99mTc-Labeled Ubiquicidin 29-41 Antimicrobial Peptide for the Scintigraphic Detection of Mediastinitis after Cardiac Surgery

Archives of Medical Research

Volumn 39, Issue 8, 2008, Pages 768-774

  Vallejo, Enrique ^a   Martinez, Irma ^a   Tejero, Alberto ^a   Hernandez, Salvador ^a   Jimenez, Luis ^a   Bialostozky, David ^a   Sanchez, Gustavo ^a   Ilarraza, Hermes ^a   Ferro Flores, Guillermina ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES   (Mexico)

Author keywords

Antimicrobial peptide; Infection imaging; Mediastinitis; Technetium imaging; Ubiquicidin

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; RADIOPHARMACEUTICAL AGENT; UBIQUICIDIN 29-41; UBIQUICIDIN 29-41 TC 99M; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; DIAGNOSTIC AGENT; PEPTIDE FRAGMENT; TECHNETIUM 99M UBIQUICIDIN(29 41); TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEART SURGERY; HUMAN; IMAGE ANALYSIS; MALE; MEDIASTINITIS; POSTOPERATIVE CARE; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; CHEMISTRY; EVALUATION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; THORAX SURGERY;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HUMANS; MALE; MEDIASTINITIS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; THORACIC SURGERY;

EID: 55249092549     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.09.002     Document Type: Article

References (39)

1. Eklund A.M., Lyytikainen O., Klemets P., Huotari K., Anttila V.J., Werkkala K.A., et al. Mediastinitis after more than 10,000 cardiac surgical procedures. Ann Thorac Surg 82 (2006) 1784-1789
2. Gardlund B., Bitkover C.Y., and Vaage J. Postoperative mediastinitis in cardiac surgery-microbiology and pathogenesis. Eur J Cardiothorac Surg 21 (2002) 825-830
3. Saad C., Barsanti S., and Trancoso V. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg 77 (2004) 676-683
4. Braxton J.H., Marrin C.A.S., McGrath P.D., Ross C.S., Morton J.R., Norotsky M., et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 70 (2000) 2004-2007
5. DeFeo M., Rezzulli A., Ismeno G., Gregorio R., Della Corte A., Utili R., et al. Variables predicting adverse outcome in patients with deep sternal wound infection. Ann Thorac Surg 71 (2001) 324-331
6. The Parisean Mediastinitis study group. Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. J Thorac Cardiovasc Surg 111 (1996) 1200-1207
7. Abboud C.S., and Firmito A.L. Evaluation of hospital infection rates and control measures in a cardiac surgery hospital: 10 years experience. Infect Control Hosp Epidemiol 21 (2000) 494-495
8. Butler J., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
9. Akman C., Kantarci F., and Cetinkaya S. Imaging in mediastinitis: a systematic review based on aetiology. Clin Radiol 59 (2004) 573-585
10. Seabold J.E., Palestro C.J., Brown M.L., Datz F.L., Forstrom L.A., Greenspan B.S., et al. Procedure guidelines for gallium scintigraphy in inflammation. J Nucl Med 38 (1997) 994-997
11. 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47 (2006) 587-594
12. Seabold J.E., Forstrom L.A., Schauwecker D.S., Brown M.L., Datz F.L., McAfee J.G., et al. Procedure guidelines for 111-indium-leukocyte scintigraphy for suspected infection/inflammation. J Nucl Med 38 (1997) 997-1001
13. Rennen H.J., Boerman O.C., Oyen W.J., and Corstens F.H. Imaging infection/inflammation in the new millennium. Eur J Nucl Med 58 (2001) 241-252
14. Datz F.L., Seabold J.E., Brown M.L., Forstrom L.A., Greenspan B.S., McAfee J.G., et al. Procedure guidelines for technetium-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection/inflammation. J Nucl Med 38 (1997) 987-990
15. Becker W., and Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 1 (2001) 326-333
16. Love C., and Palestro C.J. Radionuclide imaging of infection. J Nucl Med Technol 32 (2004) 47-57
17. 18F-FDG-labeled leukocytes. Q J Nucl Med Mol Imaging 50 (2006) 143-146
18. Bunyaviroch T., Aggarwal A., and Oates M.E. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computed tomography fusion imaging. Semin Nucl Med 36 (2006) 295-311
19. Signore A., Chianelli M., D'Alessandria C., and Annovazzi A. Receptor targeting agents for imaging inflammation/infection: where are we now?. Q J Nucl Med Mol Imaging 50 (2006) 236-242
20. Blankenberg F.G., and Strauss H.W. Nuclear medicine applications in molecular imaging: 2007 update. Q J Nucl Med Mol Imaging 51 (2007) 99-110
21. 99mTc-UBI 29-41 specificity for bacteria. Nucl Med Biol 30 (2003) 597-603
22. 99mTc-UBI 29-41 in humans. Nucl Med Biol 31 (2004) 373-379
23. 99mTc labelling of the antimicrobial peptide Ubiquicidin 29-41. J Radioanal Nucl Chem 266 (2005) 307-311
24. 99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 45 (2004) 321-326
25. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection. J Nucl Med 45 (2004) 849-856
26. Welling M.M., Paulusma-Annema A., Balter H.S., Lanzzeri S., Souto B., Rey A.M., et al. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27 (2000) 292-301
27. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 42 (2001) 788-794
28. 99mTc-antimicrobial peptides: promising candidates for infection imaging. Q J Nucl Med 47 (2003) 238-245
29. 99mTc-Ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 46 (2005) 567-573
30. Lupetti A., Welling M.M., Pauwels E.K.J., and Nibbering P.H. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 3 (2003) 223-229
31. 18F-Ubiquicidin autoradiography to anti-Staphylococcus aureus immunofluorescence in rat muscle abscesses. J Nucl Med 49 (2008) 995-999
32. 99mTc-MDP bone SPECT for the evaluation of sternal ischaemia following internal mammary artery dissection. Nucl Med Commun 23 (2002) 47-52
33. Quirce R., Carril J., Gutierrez-Mendiguchia C., Serrano J., Rabasa J.M., and Bernal J.M. Assessment of the diagnostic capacity of planar scintigraphic and SPECT with 99mTc-HMPAO-labelled leukocytes in superficial and deep sternal infections alter median sternotomy. Nucl Med Commun 23 (2002) 453-459
34. Prandini N., Lazzeri E., Rossi B., Erba P., Parisella M.G., and Signore A. Nuclear medicine imaging for bone infections. Nucl Med Commun 27 (2006) 633-644
35. Palestro C.J. In vivo leukocyte labelling: the quest continues. J Nucl Med 48 (2007) 332-334
36. 99mTc-labeled monoclonal granulocyte antibody scintigraphy. Ann Thorac Surg 62 (1996) 1412-1417
37. Becker W., Goldenberg D.M., and Wolf F. The use of monoclonal antibodies and antibody fragments on the imaging of infectious lesions. Semin Nucl Med 24 (1994) 142-153
38. Buscombe J.R. The future of infection imaging. Q J Nucl Med Mol Imaging 50 (2006) 99-103
39. Lucignani G. The many roads to infection imaging. Eur J Nucl Med Mol Imaging 34 (2007) 1873-1877